Missoula, Montana (PRWEB) August 31, 2013
Rocky Mountain Biologicals (RMBIO) (http://www.rmbio.com) announced today its attendance at the upcoming Rocky Mountain Life Science Investor and Partnering Conference (RMLIPC) on Thursday, September 19, 2013, in Denver, Colorado. Suresh Daniel, CEO of RMBIO is scheduled to present and meet with investors at the conference.
RMBIO is one of 30 regional companies chosen to present at the 2013 RMLIPC. April Giles, President and CEO of the Colorado Bioscience Association says RMBIO was selected from more than 60 applicants by a committee of investors, industry experts and representatives from partnering state bioscience associations.
“As we enter into the third RMLIPC we are thrilled by the amount of talent that calls the Rocky Mountain region home. With over 60 total company applications, we have chosen the top 30 technologies. It is important for us to showcase the best companies Colorado and the surrounding region have to offer to investors from the rest of the country,” said Giles. “We are again pleased to announce that Johnson & Johnson Development Corporation is the Founding Partner for the conference."
RMBIO is a manufacturer of bovine, porcine, equine and other custom protein products used in the Life Sciences industry. The company uses proprietary processing technology to fractionate animal blood into the growth factors required to make cell culture media. RMBIO was founded in 2004 and operates a 20,000 square foot state-of-the-art production facility in Missoula, Montana.
Additional information about the conference can be found at http://www.rockymtnbioinvest.com.